Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach (Q50234106)

28 February 2018

title

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach (English)

1 reference

28 February 2018

1

Bruno Spire

1 reference

28 February 2018

6

Jean-Paul Moatti

1 reference

28 February 2018

Catherine Leport

4

object named as

Catherine Leport

1 reference

28 February 2018

François Raffi

5

object named as

François Raffi

1 reference

28 February 2018

author name string

Ségolène Duran

2

1 reference

28 February 2018

Marc Souville

3

1 reference

28 February 2018

APROCO cohort study group

7

1 reference

28 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 February 2018

Social Science and Medicine

published in

1 reference

28 February 2018

volume

54

1 reference

28 February 2018

issue

10

1 reference

28 February 2018

page(s)

1481-1496

1 reference

28 February 2018

The era of adherence to HIV therapy

cites work

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Helping the urban poor stay with antiretroviral HIV drug therapy.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to HIV combination therapy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The relationship of disease severity, health beliefs and medication adherence among HIV patients

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Combination antiretroviral therapy: health care providers confront emerging dilemmas

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Studies of antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The Health Belief Model: A Decade Later

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Barriers to antiretroviral medication adherence in HIV-infected women.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to combination antiretroviral therapies in HIV patients of low health literacy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Developing a self-administered tool to predict adherence to antiretroviral therapy: design, method, and objectives

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Use of alternative medicine in a sample of HIV-positive gay men: An exploratory study of prevalence and user characteristics

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Management of the adverse effects of antiretroviral therapy and medication adherence

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Potential factors affecting adherence with HIV therapy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Determinants of subject compliance within an experimental anti-HIV drug protocol

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Zidovudine adherence among individuals with HIV infection

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Long-term patient adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Everyday life with AIDS/HIV: surveys in the social sciences

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence communication: a qualitative analysis of physician-patient dialogue

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence - sticking to the evidence

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Rural and urban female secondary school students' attitudes towards and use of primary care services

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Measuring medication adherence: are missed doses reported more accurately then perfect adherence?

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Development of the Multidimensional Health Locus of Control (MHLC) Scales

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

Assessing depressive symptoms in five psychiatric populations: a validation study

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(01)00125-3

7 January 2021

10.1016/S0277-9536(01)00125-3

Identifiers

DOI

1 reference

28 February 2018

1 reference

28 February 2018